Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy
NCT07423650Phase 4Recruiting
- Sponsor
- Iuliu Hațieganu University of Medicine and Pharmacy
- Start
- Mar 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nefopam in postoperative pain, sponsored by Iuliu Hațieganu University of Medicine and Pharmacy. Started Mar 2026; status: recruiting.
02
Drugs
nefopam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07423650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07423650.